Topical Antifungal Treatment for Tinea Pedis

Medicis Global Service

Status and phase: Completed; Phase 3

Conditions: Tinea Pedis

Treatments: Drug: 33525; Drug: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT01396785

MP-1000-02

Details and patient eligibility

About

The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.

Enrollment: 321 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Moderate erythema, moderate scaling, and mild pruritus

Exclusion criteria

• Pregnancy and allergies

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

321 participants in 2 patient groups, including a placebo group

Active

Experimental group

Description:

Product 33525

Treatment:

Drug: 33525

Placebo

Placebo Comparator group

Description:

Product 33525 Placebo

Treatment:

Drug: Placebo